Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-014-0066-y
Published Online: 2014-05-03
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Messori, Andrea
Fadda, Valeria
Maratea, Dario
Trippoli, Sabrina
Marinai, Claudio
Text and Data Mining valid from 2014-05-03
Article History
Received: 29 March 2014
First Online: 3 May 2014